Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V…
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
AztraZeneca to launch oncology drug Calquence in India
It is used to treat mantle cell lymphoma and chronic lymphocytic leukaemia
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so…
Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India
The Indian regulator has instructed Dr Reddy’s Laboratories carry out the trials of the vaccine with proper monitoring of immune…
Dr Reddy’s seeks DCGI approval for Phase 3 clinical trials of Sputnik V in India
The Indian pharma company has partnered with RDIF to conduct clinical trials Russian COVID-19 vaccine
The formula to step up India Nutra Inc’s success
A synopsis of the prerequisites for India Nutra Inc in its next leg of growth
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly
Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema
Intravitreal Aflibercept is administered via injection directly in the area of swelling in the eye
Serum Institute receives DCGI approval to resume trials of Oxford COVID-19 vaccine
The DCGI has, however, put certain conditions like taking extra care during screening, providing additional information in…
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients
A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support